Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
3
43%
Ph phase_4
4
57%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
4(57.1%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(3)
Terminated(3)
Other(1)

Detailed Status

Completed3
Terminated2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 44 (57.1%)
N/A3 (42.9%)

Trials by Status

completed343%
withdrawn114%
unknown114%
terminated229%

Recent Activity

0 active trials
Showing 5 of 7
withdrawnnot_applicable

Prophylaxis for Anti-VEGF-induced IOP Elevation

NCT02623023
terminatedphase_4

Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity

NCT00634972
terminatednot_applicable

Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells

NCT00478036
unknownphase_4

Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms

NCT01382810
completednot_applicable

To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops

NCT01160133
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02623023Not Applicable

Prophylaxis for Anti-VEGF-induced IOP Elevation

Withdrawn
NCT00634972Phase 4

Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity

Terminated
NCT00478036Not Applicable

Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells

Terminated
NCT01382810Phase 4

Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms

Unknown
NCT01160133Not Applicable

To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops

Completed
NCT01128556Phase 4

The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing

Completed
NCT00284999Phase 4

Soothe Versus Refresh

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7